Cargando…

A prospective study of impaired fasting glucose and type 2 diabetes in China: The Kailuan study

The worldwide prevalence and incidence of diabetes and obesity are increasing in pandemic proportions. This is particularly relevant for China, where an extremely large population is growing, aging, and urbanizing. We thus conducted a prospective study to examine the prevalence and incidence of impa...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaidya, Anand, Cui, Liufu, Sun, Lixia, Lu, Bing, Chen, Shuohua, Liu, Xing, Zhou, Yong, Liu, Xiurong, Xie, Xiaobing, Hu, Frank B., Wu, Shouling, Gao, Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120921/
https://www.ncbi.nlm.nih.gov/pubmed/27861364
http://dx.doi.org/10.1097/MD.0000000000005350
_version_ 1782469324574818304
author Vaidya, Anand
Cui, Liufu
Sun, Lixia
Lu, Bing
Chen, Shuohua
Liu, Xing
Zhou, Yong
Liu, Xiurong
Xie, Xiaobing
Hu, Frank B.
Wu, Shouling
Gao, Xiang
author_facet Vaidya, Anand
Cui, Liufu
Sun, Lixia
Lu, Bing
Chen, Shuohua
Liu, Xing
Zhou, Yong
Liu, Xiurong
Xie, Xiaobing
Hu, Frank B.
Wu, Shouling
Gao, Xiang
author_sort Vaidya, Anand
collection PubMed
description The worldwide prevalence and incidence of diabetes and obesity are increasing in pandemic proportions. This is particularly relevant for China, where an extremely large population is growing, aging, and urbanizing. We thus conducted a prospective study to examine the prevalence and incidence of impaired fasting glucose (IFG) and diabetes, the rate at which fasting blood glucose rises, and the major modifiable risk factors associated with these outcomes in a large Chinese population from the Kailuan prospective study. A prospective cohort included 100,279 Chinese participants, aged 18 years or more, who had available information on fasting blood glucose concentrations at the start of the study (2006). Examination surveys were conducted every 2 years in 2008 and 2010. For the analyses of incident diabetes, we included 76,869 participants who were free of diabetes, cardiovascular disease, and cancer at the baseline and participants in the 2008 and/or 2010 follow-up. Diabetes was defined by a fasting blood glucose concentration ≥7 mmol/L, self-reported history, or active treatment with insulin or any oral hypoglycemic agent. IFG was defined by a fasting blood glucose concentration between 5.6 and 6.9 mmol/L. During the 4-year study, the prevalence of diabetes and IFG rose from 6.6% to 7.7%, and 17.3% to 22.6%, respectively. There were 17,811 incident cases of IFG and 4867 incident cases of diabetes. The age-standardized incident rate of IFG and diabetes were 62.6/1000 person-years (51.2/1000 person-years in women and 73.8/1000 person-years in men) and 10.0/1000 person-years (7.8/1000 person-years in women and 12.1/1000 person-years in men), respectively. We observed steady increases in fasting blood glucose with body anthropometrics and in every defined category of body mass index, including in those traditionally considered to be well within the “normal” range. In this large longitudinal study of Chinese adults, we observed a high prevalence and incidence of IFG and diabetes over 4 years of follow-up. Our findings are alarming for Chinese public health since steady rises in fasting blood glucose were seen across all permutations of body habitus, even apparently very lean individuals.
format Online
Article
Text
id pubmed-5120921
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-51209212016-11-28 A prospective study of impaired fasting glucose and type 2 diabetes in China: The Kailuan study Vaidya, Anand Cui, Liufu Sun, Lixia Lu, Bing Chen, Shuohua Liu, Xing Zhou, Yong Liu, Xiurong Xie, Xiaobing Hu, Frank B. Wu, Shouling Gao, Xiang Medicine (Baltimore) 4400 The worldwide prevalence and incidence of diabetes and obesity are increasing in pandemic proportions. This is particularly relevant for China, where an extremely large population is growing, aging, and urbanizing. We thus conducted a prospective study to examine the prevalence and incidence of impaired fasting glucose (IFG) and diabetes, the rate at which fasting blood glucose rises, and the major modifiable risk factors associated with these outcomes in a large Chinese population from the Kailuan prospective study. A prospective cohort included 100,279 Chinese participants, aged 18 years or more, who had available information on fasting blood glucose concentrations at the start of the study (2006). Examination surveys were conducted every 2 years in 2008 and 2010. For the analyses of incident diabetes, we included 76,869 participants who were free of diabetes, cardiovascular disease, and cancer at the baseline and participants in the 2008 and/or 2010 follow-up. Diabetes was defined by a fasting blood glucose concentration ≥7 mmol/L, self-reported history, or active treatment with insulin or any oral hypoglycemic agent. IFG was defined by a fasting blood glucose concentration between 5.6 and 6.9 mmol/L. During the 4-year study, the prevalence of diabetes and IFG rose from 6.6% to 7.7%, and 17.3% to 22.6%, respectively. There were 17,811 incident cases of IFG and 4867 incident cases of diabetes. The age-standardized incident rate of IFG and diabetes were 62.6/1000 person-years (51.2/1000 person-years in women and 73.8/1000 person-years in men) and 10.0/1000 person-years (7.8/1000 person-years in women and 12.1/1000 person-years in men), respectively. We observed steady increases in fasting blood glucose with body anthropometrics and in every defined category of body mass index, including in those traditionally considered to be well within the “normal” range. In this large longitudinal study of Chinese adults, we observed a high prevalence and incidence of IFG and diabetes over 4 years of follow-up. Our findings are alarming for Chinese public health since steady rises in fasting blood glucose were seen across all permutations of body habitus, even apparently very lean individuals. Wolters Kluwer Health 2016-11-18 /pmc/articles/PMC5120921/ /pubmed/27861364 http://dx.doi.org/10.1097/MD.0000000000005350 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 4400
Vaidya, Anand
Cui, Liufu
Sun, Lixia
Lu, Bing
Chen, Shuohua
Liu, Xing
Zhou, Yong
Liu, Xiurong
Xie, Xiaobing
Hu, Frank B.
Wu, Shouling
Gao, Xiang
A prospective study of impaired fasting glucose and type 2 diabetes in China: The Kailuan study
title A prospective study of impaired fasting glucose and type 2 diabetes in China: The Kailuan study
title_full A prospective study of impaired fasting glucose and type 2 diabetes in China: The Kailuan study
title_fullStr A prospective study of impaired fasting glucose and type 2 diabetes in China: The Kailuan study
title_full_unstemmed A prospective study of impaired fasting glucose and type 2 diabetes in China: The Kailuan study
title_short A prospective study of impaired fasting glucose and type 2 diabetes in China: The Kailuan study
title_sort prospective study of impaired fasting glucose and type 2 diabetes in china: the kailuan study
topic 4400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120921/
https://www.ncbi.nlm.nih.gov/pubmed/27861364
http://dx.doi.org/10.1097/MD.0000000000005350
work_keys_str_mv AT vaidyaanand aprospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT cuiliufu aprospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT sunlixia aprospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT lubing aprospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT chenshuohua aprospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT liuxing aprospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT zhouyong aprospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT liuxiurong aprospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT xiexiaobing aprospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT hufrankb aprospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT wushouling aprospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT gaoxiang aprospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT vaidyaanand prospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT cuiliufu prospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT sunlixia prospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT lubing prospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT chenshuohua prospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT liuxing prospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT zhouyong prospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT liuxiurong prospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT xiexiaobing prospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT hufrankb prospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT wushouling prospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy
AT gaoxiang prospectivestudyofimpairedfastingglucoseandtype2diabetesinchinathekailuanstudy